iBio, Inc. Statistics

Total Valuation

iBio, Inc. has a market cap or net worth of $38.61 million. The enterprise value is $35.95 million.

Market Cap	38.61M
Enterprise Value	35.95M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

iBio, Inc. has 9.87 million shares outstanding. The number of shares has increased by 557.78% in one year.

Current Share Class	9.87M
Shares Outstanding	9.87M
Shares Change (YoY)	+557.78%
Shares Change (QoQ)	+5.78%
Owned by Insiders (%)	4.35%
Owned by Institutions (%)	20.58%
Float	8.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	80.49
Forward PS	187.33
PB Ratio	2.65
P/TBV Ratio	4.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	95.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.76, with a Debt / Equity ratio of 0.34.

Current Ratio	1.76
Quick Ratio	1.49
Debt / Equity	0.34
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-68.85

Financial Efficiency

Return on equity (ROE) is -123.28% and return on invested capital (ROIC) is -43.11%.

Return on Equity (ROE)	-123.28%
Return on Assets (ROA)	-34.91%
Return on Invested Capital (ROIC)	-43.11%
Return on Capital Employed (ROCE)	-91.59%
Revenue Per Employee	$23,438
Profits Per Employee	-$1.21M
Employee Count	16
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.69% in the last 52 weeks. The beta is 1.30, so iBio, Inc.'s price volatility has been higher than the market average.

Beta (5Y)	1.30
52-Week Price Change	-3.69%
50-Day Moving Average	4.16
200-Day Moving Average	2.76
Relative Strength Index (RSI)	39.09
Average Volume (20 Days)	437,215

Short Selling Information

The latest short interest is 307,797, so 3.12% of the outstanding shares have been sold short.

Short Interest	307,797
Short Previous Month	85,911
Short % of Shares Out	3.12%
Short % of Float	3.58%
Short Ratio (days to cover)	1.46

Income Statement

In the last 12 months, iBio, Inc. had revenue of $375,000 and -$19.30 million in losses. Loss per share was -$2.57.

Revenue	375,000
Gross Profit	375,000
Operating Income	-15.56M
Pretax Income	n/a
Net Income	-19.30M
EBITDA	-14.71M
EBIT	-15.56M
Loss Per Share	-$2.57

Full Income Statement

Balance Sheet

The company has $7.02 million in cash and $4.75 million in debt, giving a net cash position of $2.26 million or $0.23 per share.

Cash & Cash Equivalents	7.02M
Total Debt	4.75M
Net Cash	2.26M
Net Cash Per Share	$0.23
Equity (Book Value)	13.90M
Book Value Per Share	1.52
Working Capital	3.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.09 million and capital expenditures -$211,000, giving a free cash flow of -$16.30 million.

Operating Cash Flow	-16.09M
Capital Expenditures	-211,000
Free Cash Flow	-16.30M
FCF Per Share	-$1.65

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-4,149.33%
Pretax Margin	-3,795.73%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

iBio, Inc. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-557.78%
Shareholder Yield	-557.78%
Earnings Yield	-50.51%
FCF Yield	-42.66%

Analyst Forecast

The average price target for iBio, Inc. is $4.87, which is 24.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.87
Price Target Difference	24.55%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-34.64%

Stock Forecasts

Stock Splits

The last stock split was on November 29, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Nov 29, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

iBio, Inc. has an Altman Z-Score of -21.77 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.77
Piotroski F-Score	3